Centers

UCSC Chemical Screening Center

Presude Life Sciences

EU-OPENSCREEN

We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of...

Read more
Presude Lifesciences is an integrated drug discovery and development services organization led by biopharma professionals with global experience.

Presude is a research driven company with expertise in medicinal chemistry, custom synthesis and...

Read more
EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

Partnerships

Events

Jobs

Merck Establishes New Center in San Diego with Academic Researchers

Merck Pharmaceuticals has committed to fund $90 million over period of seven years to establish California Institute for Biomedical Research (Calibr) in San Diego, California. The new center will be led by Peter Schulz from the Scripps Research...

 
View all

Sanofi to Collaborate with UCSF to Develop New Drugs to Treat Diabetes

University of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology expertise at Sanofi will be partnering with...

 
View all

Pharma and Academia Consortium Partner to Develop New Drugs in Europe

A consortium of academic institutes from Germany, Britain, Netherlands and Denmark partner with a group of leading pharmaceutical companies which include AstraZeneca, Sanofi, Bayer, UCB , Lundbeck , Merck KGaA, and Janssen which is a JNJ...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All